Clinical and electrophysiological characteristics of Efavirenz-induced macular toxicity

Efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, is commonly used to treat HIV-infected individuals. We report a case of painless, progressive and bilateral blurring of vision in an HIV-positive 54-year-old lady within months of treatment with anti-retro viral therapy including Efa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Parveen, Sudharshan, Sridharan, Banerjee, Aniruddha, Dhami, Abhinav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113613/
https://www.ncbi.nlm.nih.gov/pubmed/32269906
http://dx.doi.org/10.3205/oc000135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113613/
https://www.ncbi.nlm.nih.gov/pubmed/32269906
http://dx.doi.org/10.3205/oc000135

Ejemplares similares